Tukysa 150 mg

TUKYSA 150 MG tablets contain tucatinib, a targeted therapy for specific medical conditions. This oral medication is designed to support treatment regimens as prescribed by healthcare professionals.

TUKYSA 150 MG tablets are primarily used in combination with other treatments for certain types of cancer. Tucatinib is a tyrosine kinase inhibitor, often utilized in advanced or metastatic cancer cases where other treatments may not be effective. The medication targets specific proteins to help manage the progression of the disease.

Common effects of TUKYSA 150 MG tablets may include fatigue, nausea, and diarrhea. Some individuals might experience changes in liver function or blood cell counts. It's important to discuss any persistent or severe effects with a healthcare provider.

TUKYSA 150 MG tablets should be handled with care, following the guidance of a healthcare professional. Regular monitoring of liver function and blood cell counts is often recommended. Pregnant women or those planning to become pregnant should consult their doctor before starting this medication.

TUKYSA 150 MG tablets may interact with other medications, including those that affect liver enzymes. It's important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.